Cancer

INDICATION: Sarcoma

Mouse studies suggest vaccines based on R123H-mutant IDH1 could help treat sarcomas harboring the mutation.

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE